The effects of darifenacin and tolterodine on heart rate (HR) in patients with overactive bladder (OAB)

被引：0
|
作者：
Olshansky, B.
Foote, J.
Arguinzoniz, M.
Lheritier, K.
Quebe-Fehling, E.
Steel, M.
机构：
[1] Univ Iowa Hosp, Iowa City, IA USA
[2] Midtown Urol & Surg Ctr, Atlanta, GA USA
[3] Novartis Pharma AG, Basel, Switzerland
来源：
NEUROUROLOGY AND URODYNAMICS | 2006年 / 25卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
124
引用
收藏
页码：656 / 657
页数：2
相关论文
共 50 条
  • [21] EXPRESSION OF URINARY CHEMOKINES IN PATIENTS WITH OVERACTIVE BLADDER (OAB)
    Faruqui, Nuzhat
    Ghoniem, Gamal
    Elmissiry, Mostafa
    Mahdy, Ayman
    Abdel-Mageed, Asim
    NEUROUROLOGY AND URODYNAMICS, 2009, 28 (02) : 107 - 107
  • [22] Identification of urinary Cytokines in patients with overactive bladder (OAB)
    Faruqui, N.
    Ghoniem, G.
    Elmissiry, M.
    Mahdy, A.
    Abdel-Mageed, A.
    INTERNATIONAL UROGYNECOLOGY JOURNAL, 2008, 19 : S151 - S152
  • [23] Simplified bladder training augments the effectiveness of tolterodine in patients with an overactive bladder
    Mattiasson, A
    Blaakaer, J
    Hoye, K
    Wein, AJ
    BJU INTERNATIONAL, 2003, 91 (01) : 54 - 60
  • [24] Urinary continence during darifenacin therapy for overactive bladder (OAB): Pooled data from phase III trials
    不详
    EUROPEAN UROLOGY SUPPLEMENTS, 2005, 4 (03) : 60 - 60
  • [25] Onset of efficacy of tolterodine extended release in patients with overactive bladder
    Sussman, David O.
    Kraus, Stephen R.
    Carlsson, Martin
    Guan, Zhonghong
    CURRENT MEDICAL RESEARCH AND OPINION, 2007, 23 (04) : 777 - 781
  • [26] Rate of discontinuation and reasons for discontinuation of intravesical onabotulinum toxin a in patients with symptomatic overactive bladder (oab)
    Scrimgeour, Gemma
    Aleksejeva, Kristina
    Axell, Richard
    Yasmin, Habiba
    Nadeem, Mehwash
    Unterberg, Stephen
    Pakzad, Mahreen
    Hamid, Rizwan
    Ockrim, Jeremy
    Greenwell, Tamsin
    NEUROUROLOGY AND URODYNAMICS, 2020, 39 : S218 - S218
  • [27] Tolterodine: A safe and effective treatment for older patients with overactive bladder
    Kausar, SA
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2002, 50 (04) : 775 - 775
  • [28] Tolterodine: A safe and effective treatment for older patients with overactive bladder
    Malone-Lee, JG
    Walsh, JB
    Maugourd, MF
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2001, 49 (06) : 700 - 705
  • [29] Propiverine versus tolterodine:: Efficacy and tolerability in patients with overactive bladder
    Jünemann, KP
    Halaska, M
    Rittstein, T
    Mürtz, G
    Schnabel, F
    Brünjes, R
    Nurkiewicz, W
    EUROPEAN UROLOGY, 2005, 48 (03) : 478 - 482
  • [30] Symptoms of overactive bladder (OAB) in patients treated for depressive disorders
    Skalski, Michal
    Przydacz, Mikolaj
    Sobanski, Jerzy A.
    Cyranka, Katarzyna
    Klasa, Katarzyna
    Datka, Wojciech
    Golabek, Tomasz
    Chlosta, Piotr
    Dudek, Dominika
    ARCHIVES OF PSYCHIATRY AND PSYCHOTHERAPY, 2020, 22 (01): : 40 - 48
12345